Hamilton O. Smith

Source: Wikipedia, the free encyclopedia.
Hamilton O. Smith
Smith in 2012
NationalityAmerican
Alma materUniversity of California, Berkeley, BA
Johns Hopkins School of Medicine, MD
Known forRestriction enzymes
AwardsNobel Prize in Physiology or Medicine in 1978
Scientific career
FieldsMolecular biology, biochemistry, genomics
InstitutionsWashington University School of Medicine

Hamilton Othanel Smith (born August 23, 1931) is an American microbiologist and Nobel laureate.[1][2]

Smith graduated from

University of Illinois at Urbana-Champaign, but in 1950 transferred to the University of California, Berkeley, where he earned his B.A. in Mathematics in 1952 [1]. He received his medical degree from Johns Hopkins School of Medicine in 1956. Between 1956 and 1957 Smith worked for the Washington University in St. Louis Medical Service. In 1975, he was awarded a Guggenheim Fellowship he spent at the University of Zurich
.

In 1970, Smith and Kent W. Wilcox discovered the first type II

methylases that constitute the other half of the bacterial host restriction and modification systems, as hypothesized by Werner Arber of Switzerland.[1]

He was awarded the Nobel Prize in Physiology or Medicine in 1978 for discovering type II restriction enzymes with Werner Arber and Daniel Nathans as co-recipients.

He later became a leading figure in the nascent field of

Celera Genomics
, which he joined when it was founded in 1998.

More recently, he has directed a team at the

Synthetic Genomics, which was founded in 2005 by Craig Venter to continue this work. Synthetic Genomics is working to produce biofuels on an industrial-scale using recombinant algae and other microorganisms.[5]

References

This article incorporates CC-BY-2.5 text from the reference[1]

Further reading

  • Lagerkvist, U (October 1978). "To split a gene".
    PMID 279742
    .

External links